- Doctors & Departments
- Conditions & Advice
- Your Visit
- Research & Innovation
Our brain tumor team delivers optimal treatment and kid-friendly care, with the goal of preserving and improving your child’s quality of life.
Our core team of pediatric-trained specialists includes:
In addition to the core neuro-oncology team members, we also work with specialists from endocrinology, neuropsychology, rehabilitation medicine, ophthalmology, radiology, nutrition, creative arts therapy, social work and counseling.
Our innovative program offers access to clinical trials, outpatient chemotherapy for infusions requiring intravenous (IV) fluids, and outpatient bone marrow transplants for certain brain tumors. This means more time at home and less time in the hospital for your child.
Learn how we're pushing the boundaries of neuro-oncology research in the video below:
Read about our Experimental Therapeutics Program for brain tumors that don’t respond well to traditional treatments.
We understand that a brain tumor diagnosis doesn’t just affect the patient – it impacts the whole family. That’s why we have the following support services to help families manage a brain tumor diagnosis and treatment:
By publishing 15 to 20 prestigious academic papers each year, our neuro-oncology doctors and nurse practitioners are also leading researchers in their field. The team is heavily involved in the International Symposium of Pediatric Neuro-Oncology (ISPNO) and Children’s Oncology Group, meaning we work with experts around the world to come up with new and improved brain tumor treatment options for the future.
We're part of a select group of institutions to join to the Pediatric Brain Tumor Consortium (PBTC). The PBTC is a multidisciplinary research organization devoted to studying new therapies for childhood central nervous system tumors. The primary mission of the PBTC is to identify superior treatment strategies for children with brain cancers through laboratory and clinical science. The lead investigators at Children's Colorado are Dr. Kathleen Dorris and Dr. Rajeev Vibhakar.
Advancing Treatment for Pediatric Craniopharyngioma (ATPC) is North America’s first multicenter consortium dedicated exclusively to the discovery and testing of novel therapies for children with adamantinomatous craniopharyngioma (ACP). The goal is to offer new therapies that will improve the quality of life for children with ACP. Read how we're collaborating to improve treatment for this uncommon, slow-growing brain tumor.
Our Neuro-oncology Program partners with Endocrinology specialists like Becca Sachs, PA-C, who are an active part of the patient's care team, seeing them in the middle of treatment or after.
“It’s a constant stream of communication between neuro-onc and endocrine,” Sachs says. She educates patients about potential problems; after they’ve completed oncology treatment, she has regular check-ups and prescribes medication as needed. Patients remain at risk for developing endocrinopathy even 5 to 10 years out from treatment.
“We’ve seen lots of success stories,” she says. “It continues to feed our belief in our multidisciplinary care model.”
Learn about the signs, symptoms and treatment of brain tumors.
Hematology/Oncology - Pediatric , Pediatrics
Neurosurgery, Neurosurgery - Pediatric
Certified Pediatric Nurse Practitioner